Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal-Reference-Cited by-同舟云学术

Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal

Published:2016-01-29 Issue:9 Volume:29 Page:961-973
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Rodríguez-Perálvarez Manuel¹,Rico-Juri Jose M.²,Tsochatzis Emmanuel³,Burra Patrizia⁴,De la Mata Manuel¹,Lerut Jan²

Affiliation:

1. Department of Hepatology and Liver Transplantation; Reina Sofía University Hospital; IMIBIC; CIBERehd; Córdoba Spain

2. Starzl Unit of Abdominal Transplantation; Cliniques Universitaires Saint Luc; Université Catholique de Louvain (UCL); Brussels Belgium

3. UCL Institute for Liver and Digestive Health and Sheila Sherlock Liver Unit; Royal Free Hospital and UCL; London UK

4. Multivisceral Transplant Unit Gastroenterology; Padova University Hospital; Padova Italy

Funder

European Association for the Study of the Liver (EASL)

Fresenius Biotech

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12737/fullpdf

Reference112 articles.

1. Liver Transplantation: Prevention and Treatment of Rejection

2. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers;Thorpe;J Clin Epidemiol,2009

3. Safety and efficacy of steroid-free immunosuppression post-liver transplantation: a randomised phase III trial comparing tacrolimus monotherapy after daclizumab induction versus tacrolimus+MMF dual therapy;Bilbao;J Hepatol,2009

4. A randomized, single-center trial comparing thymoglobulin (TG) induction therapy and delayed initiation of tacrolimus to no induction with immediate initiation of tacrolimus in liver transplant (LT) recipients to assess the impact on renal function;Grant;Am J Transplant,2012

5. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR);Adam;J Hepatol,2012

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant Immunology in Liver Transplant, Rejection, and Tolerance;Livers;2024-09-09

2. Computational identification of novel potential genetic pathogenesis and otherwise biomarkers in acute liver allograft rejection;Heliyon;2024-08

3. Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?;World Journal of Transplantation;2024-06-18

4. Detection of inflammasome activation in liver tissue during the donation process as potential biomarker for liver transplantation;Cell Death Discovery;2024-05-30

5. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient;Acta Clinica Belgica;2024-05-03